-
13th listing of 2023 on Euronext Growth Milan
-
International Medical Device S.p.A. brings the total number of companies listed on Euronext Growth Milan to 194
-
30th listing on Euronext in 2023
-
Total placement volume of the offering equal to €5.97 million
Milan – 7 July 2023 – Borsa Italiana, part of the Euronext Group, today congratulates International Medical Device S.p.A. on its listing on Euronext Growth Milan.
International Medical Device S.p.A. operates in the medtech sector, particularly in research and development, production and distribution of a wide range of X-Ray diagnostic systems. Through its three operating companies (Technix S.p.A., IMD Generators S.r.l. and Intermedical S.r.l.), the IMD Group has been active in the medical field for more than 40 years, offering highly innovative and cutting-edge solutions in terms of diagnostic imaging.
International Medical Device S.p.A. represents the thirteenth listing on Euronext Growth Milan, the market dedicated to small and medium-sized companies, the thirtieth listing on Euronext in 2023, and it brings the total number of firms currently listed on Euronext Growth Milan to 194.
In the placement phase, International Medical Device S.p.A. raised €5.42 million.
In the case of the full exercise of the over-allotment option, the total amount raised will be €5.97 million. The free float at the time of admission was 15% and the market capitalisation at IPO was €36.2 million.
Aniello Aliberti, CEO and Chairman of International Medical Device S.p.A., said: “The listing on EGM represents a milestone on the growth path that will allow us both to support the development programme by external lines, through M&A transactions, and the strengthening of our production and managerial capabilities. Our core business is oriented towards the continuous development of innovative technological solutions in the medical field aimed at the production of devices aimed at the preservation of health. Our goal, in fact, is to create value in terms of reliability and quality, positioning ourselves as a reference player capable of providing the Made In Italy efficiency and know-how that we have developed in over 40 years of activity. Confident to continue on our path with enthusiasm, we look to the future with renewed optimism, aware of achieving increasingly ambitious challenges. Special thanks to all the employees who with their constant commitment have contributed to the growth of our Group, to all the advisors who have supported us on this path of preparation for the listing, and to the investors and Dornier who have decided to put their trust in the future development project”.
Caption Aniello Aliberti, CEO and Chairman of International Medical Device S.p.A., rang the bell during the market open ceremony this morning to celebrate the Initial Public Offering of the company.
International Medical Device S.p.A.
I.M.D. International Medical Devices S.p.A. is the holding company of the IMD Group of the same name, which operates in the MedTech sector, specifically in the research and development, production and distribution of a wide range of X-Ray diagnostic systems. Through its three operating companies (Technix S.p.A., IMD Generators S.r.l. and Intermedical S.r.l.), IMD Group has more than 40 years of experience in the medical sector, basing its growth path on design capabilities that have enabled the development of highly innovative and cutting-edge solutions capable of capturing the trends and the highest standards of quality and safety in the industry. The business model is divided into the two areas: X-Ray Generators (through the subsidiary IMD Generators) referring to the development, production and marketing of monoblocks, RX generators and control systems (crucial components for medical equipment) and X-Ray Imaging Devices (through the subsidiaries Technix and Intermedical) referring to the development, production and marketing of the entire medical equipment (analog or digital) used in different medical fields such as, orthopedic, urological, emergency room and operating rooms.